证据证明CME的有效性. 一项对50项随机对照试验的审查
D A Davis1, M A Thomson, A D Oxman
1Department of Family Medicine, School of Occupational Therapy and Physiotherapy, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
JAMA
|September 2, 1992
概括
持续医学教育 (CME) 干预措施支持医生实践,显著改善表现,并可以提高患者的健康结果. 这些发现凸显了医疗保健中有针对性的教育策略的价值.
科学领域:
- 医学教育研究 医学教育研究
- 改善医疗保健质量 改善医疗保健质量
- 医生专业发展医生专业发展
背景情况:
- 持续医学教育 (CME) 对于维持和提高医生专业知识至关重要.
- 评估各种CME干预措施对临床实践和患者结果的有效性对于医疗保健质量至关重要.
研究的目的:
- 系统地评估各种持续医学教育 (CME) 干预措施对医生的表现和患者健康结果的影响.
- 综合来自随机对照试验中关于CME疗效的证据.
主要方法:
- 在多个数据库 (MEDLINE等) 中进行了全面的文献搜索. 从1975年到1991年,他一直在工作.
- 研究是根据包括随机对照试验,医生专注干预和客观结果评估在内的标准进行选择的.
- 提取和分类了医生专业,环境,干预类型和结果 (表现和患者) 的数据.
主要成果:
- 在777项确定的研究中,有50项符合纳入标准.
- 大多数专注于医生表现的研究表明,对资源利用,咨询和预防性护理有积极的影响.
- 评估医疗保健结果的大量研究表明,患者健康状况发生了积极变化.
结论:
- 广泛定义的CME干预措施,特别是那些采用实践启用或强化策略的干预措施,始终导致医生绩效的提高.
- 在某些情况下,这些有效的CME策略也可以积极影响患者的医疗保健结果.
更多相关视频
相关概念视频
Multiple Comparison Tests
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


